Proteome Sciences Settles with Sanofi-Aventis for $15M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK proteomics services provider and reagents firm Proteome Sciences today said they have received €11 million ($15 million) from Sanofi-Aventis Deutschland to settle a claim alleging breach of certain warranties.

Proteome Sciences also announced that its revenues for the first half of 2010 more than doubled compared to a year ago while its net loss narrowed by 10 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.